So, pemigatinib is this special kind of drug that blocks something called FGFR, which is super important for those with cholangiocarcinoma, specifically when there’s a thing called FGFR2 fusion. It really stops this FGFR signaling thing in its tracks, you know, which is a big deal in cancer cells. You can get this stuff in three different tablet sizes: 4.5 mg, 9 mg, or the biggest one at 13.5 mg.
They suggest taking 13.5 mg of this stuff every day for about two weeks every month, on a cycle of three weeks. Each pack comes in a bottle with 14 tablets.
